Research and Markets: Interferons Expected to Drive Growth in Market for Therapeutic Proteins?

(PRWEB) October 7, 2004 -- Research and Markets (http://www.researchandmarkets.com) has announced the addition of The Therapeutic Proteins Outlook To 2007: An analysis of leading products and late-stage pipeline developments to their offering

The therapeutic proteins market is thriving, generating global sales of $33,340m in 2002, a 24% increase upon 2001 sales of $26,881m.
This report is a timely global market assessment of the ten major therapeutic protein classes. This report provides product forecasts to 2007, and defines the driving forces that will impact the therapeutic proteins market, outlining the future competitive landscape. This report provides a single source of key product and sales analysis, summarizing changing competitive dynamics and developments to the market therapeutic proteins. This report will aid understanding of the key growth areas and also details whether interferons will continue to be the major driver of overall growth in the next five years.

Topics covered include:
-   Overview of the global therapeutic proteins market
-   Erythropoietins
-   Interferons
-   Insulins
-   Monoclonal antibodies
-   Blood factors
-   Colony stimulating factors
-   Growth hormones
-   Interleukins
-   Growth factors
-   Therapeutic vaccines
-   Other therapeutic proteins

For more information visit http://www.researchandmarkets.com/reports/c5585

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980